Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade

International Journal of Molecular Medicine

Volumn 27, Issue 6, 2011, Pages 811-819

  Adler, David ^a   Lindstrot, Andreas ^a   Langer, Berit ^a   Buettner, Reinhard ^a   Wernert, Nicolas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Angiogenesis; Apoptosis; Migration; Proliferation; Transcriptional regulation

Indexed keywords

TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN FAMILY; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING;

EID: 79954522603     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.652     Document Type: Article

References (53)

1. Kohn EC: Invasion and metastasis: biology and clinical potential. Pharmacol Ther 52: 235-244, 1991.
2. Duffy MJ, McGowan PM and Gallagher WM: Cancer invasion and metastasis: changing views. J Pathol 214: 283-293, 2008. (Pubitemid 351212383)
3. Oikawa T: ETS transcription factors: possible targets for cancer therapy. Cancer Sci 95: 626-633, 2004.
4. Hashiya N, Jo N, Aoki M, et al: In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109: 3035-3041, 2004.
5. Rothhammer T, Hahne JC, Florin A, et al: The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128, 2004. (Pubitemid 38121905)
6. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F and Wernert N: Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene 24: 5384-5388, 2005. (Pubitemid 43080108)
7. He J, Pan Y, Hu J, Albarracin C, Wu Y and Dai JL: Profile of Ets gene expression in human breast carcinoma. Cancer Biol Ther 6: 76-82, 2007. (Pubitemid 46294180)
8. Wasylyk B, Hahn SL and Giovane A: The Ets family of transcription factors. Eur J Biochem 211: 7-18, 1993. (Pubitemid 23039491)
9. Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S and Wernert N: The transcription factor ETS-1: its role in tumor development and strategies for its inhibition. Mini Rev Med Chem 8: 1095-1105, 2008.
10. Tomlins SA, Rhodes DR, Perner S, et al: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648, 2005. (Pubitemid 41528150)
11. Furusato B, Tan SH, Young D, et al: ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer Prostatic Dis 13: 228-237, 2010.
12. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N: The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50, 2001.
13. Behrens P, Mathiak M, Mangold E, et al: Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer 107: 183-188, 2003. (Pubitemid 37152895)
14. Alipov G, Nakayama T, Ito M, et al: Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology 46: 202-208, 2005. (Pubitemid 40293019)
15. Hahne JC, Kummer S, Heukamp LC, et al: Regulation of protein tyrosine kinases in tumor cells by the transcription factor Ets-1. Int J Oncol 35: 989-996, 2009.
16. Wernert N, Stanjek A, Kiriakidis S, et al: Inhibition of angiogenesis in vivo by ets-1 antisense oligonucleotides-inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin. Angew Chem Int Ed Engl 38: 3228-3231, 1999. (Pubitemid 29533905)
17. Wernert N, Gilles F, Fafeur V, et al: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688, 1994. (Pubitemid 24346267)
18. Wernert N, Raes MB, Lassalle P, et al: c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140: 119-127, 1992.
19. Sahin A, Vercamer C, Kaminski A, et al: Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes. Int J Oncol 34: 377-389, 2009.
20. Koochekpour S: Androgen receptor signaling and mutations in prostate cancer. Asian J Androl 12: 639-657, 2010.
21. Alimirah F, Chen J, Davis FJ and Choubey D: IFI16 in human prostate cancer. Mol Cancer Res 5: 251-259, 2007.
22. Roca H, Varsos Z and Pienta KJ: CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem 283: 25057-25073, 2008.
23. Zhang J, Patel L and Pienta KJ: CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine Growth Factor Rev 21: 41-48, 2009.
24. Massoner P, Colleselli D, Matscheski A, et al: Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility. Endocr Relat Cancer 16: 795-808, 2009.
25. Palmer DH, Hussain SA, Ganesan R, et al: CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule. Oncol Rep 12: 679-682, 2004.
26. Das S, Roth CP, Wasson LM and Vishwanatha JK: Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Prostate 67: 1550-1564, 2007. (Pubitemid 47536154)
27. Wlazlinski A, Engers R, Hoffmann MJ, et al: Downregulation of several fibulin genes in prostate cancer. Prostate 67: 1770-1780, 2007. (Pubitemid 350228729)
28. Liao YC and Lo SH Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J Biochem Cell Biol 40: 843-847, 2008.
29. Zhou X, Yang XY and Popescu NC: Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics. Int J Oncol 36: 999-1005, 2010.
30. Fang X, Liu Z, Fan Y, et al: Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor. Int J Cancer 118: 2485-2489, 2006.
31. Hua D, Liu MY, Cheng ZD, et al: Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 46: 2876-2884, 2009.
32. Dong Z, Liu Y, Lu S, et al: Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Mol Endocrinol 20: 2315-2325, 2006. (Pubitemid 44496404)
33. Lee K, Liu Y, Mo JQ, Zhang J, Dong Z and Lu S: Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. BMC Cancer 8: 158, 2008.
34. McJilton MA, Van Sikes C, Wescott GG, et al: Protein kinase C epsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene 22: 7958-7968, 2003. (Pubitemid 37175861)
35. Quirosa Flores S, Varsavsky M, Valle Diaz De La Guardia F, et al: Secondary hyperparathyroidism in advanced prostate cancer. Endocrinol Nutr 57: 100-104, 2010.
36. Loberg RD, Neeley CK, Adam-Day LL, et al: Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology. Int J Oncol 26: 1699-1705, 2005.
37. Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LW and O'Hara SM: Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Res 66: 2918-2922, 2006.
38. Bai AS, Zeng H, Li X, Wei Q, Li H and Yang YR: Expression of kinase insert domain-containing receptor in prostate adenocarcinoma. Zhonghua Nan Ke Xue 13: 324-326, 2007 (In Chinese).
39. Chen CA and Okayama H: Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6: 632-638, 1988.
40. Wellmann A, Wollscheid V, Lu H, et al: Analysis of microdissected prostate tissue with ProteinChip arrays - a way to new insights into carcinogenesis and to diagnostic tools. Int J Mol Med 9: 341-347, 2002.
41. Okuducu AF, Janzen V, Hahne JC, Ko Y and Wernert N: Influence of histochemical stains on quantitative gene expression analysis after laser-assisted microdissection. Int J Mol Med 11: 449-453, 2003.
42. Okuducu AF, Hahne JC, Von Deimling A and Wernert N: Laser-assisted microdissection, techniques and applications in pathology (Review). Int J Mol Med 15: 763-769, 2005.
43. Transcriptional Regulatory Element Database, http://rulai.cshl.edu/TRED/, Cold Spring Harbor Laboratory, Cold Spring, Harbor, NY.
44. Shaikhibrahim Z, Laager B, Lindstrot A, et al: Ets-1 is implicated in the regulation of androgen Co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 Prostate Cancer Cells. Oncol Rep (In Press).
45. Holterman CE, Franovic A, Payette J and Lee S: ETS-1 oncogenic activity mediated by transforming growth factor alpha. Cancer Res 70: 730-740, 2010.
46. Feldman BJ and Feldman D: The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34-45, 2001. (Pubitemid 33741879)
47. Balk SP: Androgen receptor as a target in androgen-independent prostate cancer. Urology 60: 132-139, 2002.
48. Hiratsuka S, Watanabe A, Sakurai Y, et al: The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10: 1349-1355, 2008.
49. Andreani V, Gatti G, Simonella L, Rivero V and Maccioni M: Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo. Cancer Res 67: 10519-10527, 2007. (Pubitemid 350070828)
50. Nguyen VT and Benveniste EN: Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem 275: 23674-23684, 2000. (Pubitemid 30624652)
51. Prieur A, Tiro de F, Cohen P and Delattre O: EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol 24: 7275-7283, 2004. (Pubitemid 39014452)
52. Heydemann A, Juang G, Hennessy K, Parmacek MS and Simon MC: The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor. Mol Cell Biol 16: 1676-1686, 1996.
53. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R and Beutler B: PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 275: 9773-9781, 2000. (Pubitemid 30185212)